Antiva Biosciences

Website
Current Valuation
$123.0M
As of October 11, 2024
Total Funding Raised
$144.8M
Last Round
Later Stage VC

$53.0M

Last Funding
Oct 2024

Funding date

Capital Efficiency
0.85x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Antiva Biosciences is currently valued at $123.0M as of October 11, 2024. The company has raised a total of $144.8M in funding.

Capital Efficiency

With a capital efficiency ratio of 0.85x, Antiva Biosciences has achieved a valuation that is 0.85 times the total capital raised.

Track Antiva Biosciences Valuation Updates

Get notified when Antiva Biosciences raises new funding or valuation changes

Explore More Data
Detailed analysis for Antiva Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Antiva Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Antiva Biosciences Worth in 2026?

Antiva Biosciences is a leading private company in the technology sector. Track Antiva Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Antiva Biosciences Valuation is Determined

Private company valuations like Antiva Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.